Hepatocellular carcinoma (HCC) is the most common primary liver neoplasm and one of the
most common causes of death in patients with cirrhosis of the liver. In parallel with …

Background Hepatocellular carcinoma (HCC) is the most common malignant tumor
worldwide. Circular RNAs (circRNAs), a new class of endogenous non-coding RNAs, are …

Purpose Early-stage hepatocellular carcinoma (E-HCC) is being diagnosed increasingly,
and in one half of diagnosed patients, recurrence will develop. Thus, it is urgent to identify …

Hepatocellular carcinoma (HCC) is well known as the sixth most common malignant tumor
and the third leading cause of cancer-related deaths globally. LINC00152 was documented …

Background: In the present study, we assessed the clinical value of circulating tumor cells
(CTC) with stem-like phenotypes for diagnosis, prognosis, and surveillance in hepatitis B …

Clinical studies in a range of cancers have detected elevated levels of the Wnt antagonist
Dickkopf-1 (DKK1) in the serum or tumors of patients, and this was frequently associated …

The ability to simultaneously monitor multiple analytes in, for example, a single microplate
well, is important for both basic research and clinical applications. In particular, for disease …

Hepatocellular carcinoma (HCC) was the third leading cause of cancer-related death
globally in 2020. The treatment of the disease is complex, with a high possibility of disease …

Wnt signalling is a fundamental pathway involved in embryonic development and adult
tissue homeostasis. Mutations in the pathway frequently lead to developmental defects and …

METHODS In this study, we applied an lncRNA microarray to screen the potential biomarker
for HCC. The multi-stage validation and risk score formula detection was used for validation …